GGrantIndex
Sort

15,842 grants matching pancreatic cancer

High dose radiation therapy to direct immune responses to pancreatic cancer

$321,625
Michael James Gough · Providence Portland Medical Center · R01 · FY2014 · CA

High dose radiation therapy to direct immune responses to pancreatic cancer

$321,625
Michael James Gough · Providence Portland Medical Center · R01 · FY2015 · CA

Chemoprevention of Pancreatic Cancer by Capsaicin

$321,568
Sanjay K Srivastava · Texas Tech University Health Scis Center · R01 · FY2009 · CA

Pancreas Transcription Factor and Disease Model System

$321,551
Stephen F Konieczny · Purdue University · R01 · FY2009 · DK

Role of HSP70 in Pancreatic Diseases

$321,544
Sundaram Ramakrishnan · University Of Miami School Of Medicine · R01 · FY2022 · CA

Investigation of the Cell-of-Origin and Cancer Stem Cells in Pancreatic Adenocarc

$321,427
Tyler E Jacks · Dana-Farber Cancer Inst · P01 · FY2007 · CA

Kinase Target of Diverse Cell Surface Receptors in Cancer Invasion and Metastasis

$321,264
Ann Marie Pendergast · Duke University · R01 · FY2015 · CA

Hedgehog Inhibitors in Pancreas Cancer

$321,185
Johns Hopkins University · R01 · FY2005 · CA

Control of Diabetes by Manipulation of Bc12 Family Members

$321,129
Jonathan David Katz · Cincinnati Childrens Hosp Med Ctr · R01 · FY2013 · DK

Project 4: Prognostic Significance and Therapeutic Potential of DROSHA Mutations in Wilms Tumor

$321,044
James F Amatruda · Ut Southwestern Medical Center · P50 · FY2020 · CA

DIABETES AND ENDOCRINOLOGY RESEARCH CENTER

$321,030
Joslin Diabetes Center · P30 · FY2001 · DK

Chemoprevention of Pancreatic Cancer by Capsaicin

$321,017
Sanjay K Srivastava · Texas Tech University Health Scis Center · R01 · FY2010 · CA

Uncovering Role of Exosomes in Regulating Pancreatic Cancer Cell Metabolism

$320,959
Deepak Nagrath · University Of Michigan At Ann Arbor · R01 · FY2018 · CA

Project 3 - HDAC/GSK-3B/YAP signaling network in the liver metastatic microenvironment

$320,917
Stephen J Pandol · Cedars-Sinai Medical Center · P01 · FY2022 · CA

Small Molecule Antibody Mimics: Toward a New Paradigm in Targeted Cancer Therapy

$320,875
David Adam Spiegel · Yale University · R01 · FY2012 · GM

Role of Glypican-1 in Pancreatic Cancer

$320,862
Murray Korc · Dartmouth College · R01 · FY2007 · CA

Core B: Biospecimen Core

$320,833
Ryan C Fields · Washington University · P50 · FY2016 · CA

RIBONUCLEASES IN CANCER CHEMOTHERAPY

$320,772
University Of Wisconsin Madison · R01 · FY2004 · CA

Targeting Transglutaminase 2 in cancer cachexia

$320,726
Azeddine Atfi · Virginia Commonwealth University · R01 · FY2024 · CA

A Pilot Clinical Trial of Paricalcitol for Chronic Pancreatitis

$320,724
Stephen J Pandol · Cedars-Sinai Medical Center · R01 · FY2022 · DK

Suppression of pancreatic tumorigenesis by the PTF1 transcription factor network

$320,718
Lewis C Murtaugh · University Of Utah · R01 · FY2017 · CA

Access of Therapeutic Agents to Cancer Cells

$320,633
Shibin Zhou · Johns Hopkins University · P50 · FY2016 · CA

Targeting BET Bromodomain in Pancreatic Cancer

$320,588
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2017 · CA

Distinctive Glycan Fingerprints of Pancreatic Cancer for Plasma Detection

$320,588
David E Misek · University Of Michigan At Ann Arbor · R01 · FY2009 · CA

Targeting BET Bromodomain in Pancreatic Cancer

$320,588
Hidayatullah G Munshi · Northwestern University At Chicago · R01 · FY2015 · CA